Procter & Gamble Gains 9.24% Month to Date, Forward P/E at 23.48
Procter & Gamble shares gained 9.24% over past month, outperforming the Consumer Staples sector’s 8.64% gain and the S&P 500’s 0.5% loss. Analysts forecast Q2 EPS of $1.57 (up 1.95% YoY) and full-year EPS of $6.97 (up 2.05%), while forward P/E of 23.48 exceeds the industry average of 20.35.
1. Recent Share Performance
Procter & Gamble shares rose 2.11% in the latest session, outpacing the S&P 500’s 0.43% decline, the Dow’s 1.05% drop and the Nasdaq’s 0.92% fall. Over the past month, shares climbed 9.24%, ahead of the Consumer Staples sector’s 8.64% gain and contrasting with the S&P 500’s 0.5% loss.
2. Earnings Projections
Second-quarter EPS are projected at $1.57, marking a 1.95% year-over-year increase, with revenue forecast at $20.61 billion, up 4.2%. Full-year consensus estimates call for EPS of $6.97 (up 2.05%) and revenue of $86.71 billion (up 2.88%).
3. Valuation Metrics
Procter & Gamble’s forward P/E stands at 23.48, a premium to the industry average of 20.35. The stock’s PEG ratio of 5.47 also exceeds the industry norm of 3, reflecting higher valuation relative to expected earnings growth.
4. Analyst Rankings and Revisions
The company holds a Zacks Rank of #3 (Hold) after a 0.02% decline in consensus EPS estimates over the past 30 days. These estimate revisions often signal short-term share momentum and shifting analyst sentiment.